refractory anemia

Also found in: Thesaurus, Medical, Acronyms, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.refractory anemia - any of various anemic conditions that are not successfully treated by any means other than blood transfusions (and that are not associated with another primary disease)
sideroblastic anaemia, sideroblastic anemia, siderochrestic anaemia, siderochrestic anemia - refractory anemia characterized by sideroblasts in the bone marrow
anemia, anaemia - a deficiency of red blood cells
References in periodicals archive ?
Recurrent abdominal pain, failure to thrive or patients only with short stature and refractory anemia are prominent features in NCDC group whereas abdominal distension, failure to thrive and recurrent abdominal pain were noticeable features in CCD.
Helicobacter pylori gastric infection and sideropenic refractory anemia.
Enterolithiasis, refractory anemia, and strictures of Crohn's disease.
USPRwire, Tue Nov 03 2015] GlobalData's clinical trial report, "Refractory Anemia With Excess Blasts Global Clinical Trials Review, H2, 2015" provides an overview of Refractory Anemia With Excess Blasts clinical trials scenario.
GlobalData's clinical trial report, "Refractory Anemia Global Clinical Trials Review, H2, 2015" provides an overview of Refractory Anemia clinical trials scenario.
We present an unusual case of myeloid sarcoma of the bladder in a patient with therapy related refractory anemia with excess blasts-2 (RAEB-2).
Siddappa and colleagues presented a rare case of renal hemosiderosis appearing with renal failure due to repeated blood transfusion (about 2 per month) over past 2 years for chronic refractory anemia.
Of the nine cases of myelodysplastic syndrome, four were refractory anemia (RA), one was refractory anemia with ring sideroblast (RARS), two were refractory cytopenia with multilineage dysplasia and two had refractory Anemia with excess blast (RAEB).
14 December 2011 - US RNAi therapeutics company Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) said yesterday that it presented new pre-clinical data from ALN-APC for the treatment of hemophilia, ALN-HPN for the treatment of refractory anemia and a pre-clinical research from candidate programmes in beta-thalassemia and erythropoiesis, at the 53 American Society of Hematology (ASH) annual meeting held in San Diego, CA, USA.